Chemerin was first described as tazarotene-induced gene 2 protein (TIG2) in patients with psoriasis; expression of this gene was intensified in patients treated with the antipsoriatic retinoic acid tazarotene [4]. This evidence concerns the gene RARRES2 and psoriasis.